Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease

Clinical trial NCT06732180 · RECRUITING

Trial details

NCT number: NCT06732180
Sponsor: Gain Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2025-02-21
Primary completion: 2025-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.